IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gendron, R. L.
Right arrow Articles by Paradis, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gendron, R. L.
Right arrow Articles by Paradis, H.
(Investigative Ophthalmology and Visual Science. 2001;42:3000-3007.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

Suppressed Expression of Tubedown-1 in Retinal Neovascularization of Proliferative Diabetic Retinopathy

Robert L. Gendron1, William V. Good2, Lisa C. Adams1 and Hélène Paradis1

1 From the Department of Pediatrics, University of Cincinnati College of Medicine, Division of Hematology and Oncology, The Children’s Hospital Research Foundation, Cincinnati, Ohio; and the 2 Smith-Kettlewell Eye Research Institute, San Francisco, California.

PURPOSE. Retinal neovascularization occurring as a complication of diabetes mellitus can cause vision loss and blindness. The identification and study of novel genes involved in retinal angiogenesis may define new targets to suppress retinal neovascularization in diabetes and other ocular diseases. A novel acetyltransferase subunit, tubedown-1 (tbdn-1), has been isolated, the expression of which is regulated during blood vessel development. Tbdn-1 is not detected in most adult vascular beds but persists at high levels in the adult ocular vasculature. The purpose of this study was to gain insight into the possible role of tbdn-1 in retinal blood vessels by characterizing its expression patterns in adult homeostasis and in retinal neovascularization associated with diabetes.

METHODS. Western blot analysis and immunohistochemistry were performed to study the expression patterns of tbdn-1 during adult homeostasis in normal human retinas, in a model of choroid–retina endothelial capillary outgrowth in vitro, and in retinas showing neovascularization in patients with proliferative diabetic retinopathy (PDR).

RESULTS. In adults during homeostasis, tbdn-1 was expressed highly in normal endothelium of retinal and limbic blood vessels. Tbdn-1 was also expressed in RF/6A, a rhesus macaque choroid-retina–derived endothelial cell line. In an in vitro model system using the RF/6A cell line, tbdn-1 expression was downregulated during the outgrowth of these cells into capillary-like structures on a reconstituted basement membrane matrix. Similar to this in vitro model, tbdn-1 expression is specifically suppressed in the endothelial cells of blood vessels and capillary fronds in vivo in both the neural retinal tissue and in preretinal membranes in eyes of patients with PDR.

CONCLUSIONS. High levels of expression of tbdn-1 are associated with ocular endothelial homeostasis in adults. Conversely, low levels of tbdn-1 expression are associated with endothelial capillary outgrowth in vitro and retinal neovascularization in vivo. Because the tbdn-1 acetyltransferase subunit is a member of a family of regulatory enzymes that are known to control a range of processes, including cell growth and differentiation, through posttranslational modification, the current results support a hypothesis that tbdn-1 may be involved in maintaining homeostasis and preventing retinal neovascularization.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
H. Paradis, T. Islam, S. Tucker, L. Tao, S. Koubi, and R. L. Gendron
Tubedown associates with cortactin and controls permeability of retinal endothelial cells to albumin
J. Cell Sci., June 15, 2008; 121(12): 1965 - 1972.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. T. Martin, R. L. Gendron, J. A. Jarzembowski, A. Perry, M. H. Collins, C. Pushpanathan, E. Miskiewicz, V. P. Castle, and H. Paradis
Tubedown Expression Correlates with the Differentiation Status and Aggressiveness of Neuroblastic Tumors
Clin. Cancer Res., March 1, 2007; 13(5): 1480 - 1487.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Bilton, N. Mazure, E. Trottier, M. Hattab, M.-A. Dery, D. E. Richard, J. Pouyssegur, and M. C. Brahimi-Horn
Arrest-defective-1 Protein, an Acetyltransferase, Does Not Alter Stability of Hypoxia-inducible Factor (HIF)-1{alpha} and Is Not Induced by Hypoxia or HIF
J. Biol. Chem., September 2, 2005; 280(35): 31132 - 31140.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
W V Good and R L Gendron
Retinopathy of prematurity's turning point
Br. J. Ophthalmol., February 1, 2005; 89(2): 127 - 128.
[Full Text] [PDF]


Home page
IOVSHome page
D. S. Wall, R. L. Gendron, W. V. Good, E. Miskiewicz, M. Woodland, K. Leblanc, and H. Paradis
Conditional Knockdown of Tubedown-1 in Endothelial Cells Leads to Neovascular Retinopathy
Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3704 - 3712.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology